All Insights

Accelerated Innovation Is the Key to the UK’s Post-Brexit Life Sciences Leadership

With the UK leaving the EU, Haig was asked about the potential impact on Life Sciences and has written an article published in the Pharma’s Almanac on the importance of staying ahead of the curve and accelerating innovation in spite of the upcoming regulatory change turbulence.

See the full article here:


Source – Pharma’s Almanac